---
title: "Renatus Tactical Acquisition Corp I | 10-Q: FY2026 Q1 Revenue: USD 0"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286308725.md"
datetime: "2026-05-13T20:02:40.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286308725.md)
  - [en](https://longbridge.com/en/news/286308725.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286308725.md)
---

# Renatus Tactical Acquisition Corp I | 10-Q: FY2026 Q1 Revenue: USD 0

Revenue: As of FY2026 Q1, the actual value is USD 0.

EPS: As of FY2026 Q1, the actual value is USD 0.08.

EBIT: As of FY2026 Q1, the actual value is USD -2.374 M.

Renatus Tactical Acquisition Corp I operates as a blank check company without operational revenues, focusing on its Initial Public Offering (IPO) and identifying a target for a Business Combination. The company generates non-operating income from interest on marketable securities held in its Trust Account .

#### Financial Performance (Three Months Ended March 31, 2026)

-   Net Income: $1,808,560
-   Investment Income (Trust Account): $2,091,474
-   Formation and Operating Expenses: $282,914

#### Cash Flow (Three Months Ended March 31, 2026)

-   Net Cash Used in Operating Activities: - $77,594
    -   This figure includes net income of $1,808,460, offset by interest earned on cash held in the Trust Account of - $2,091,474, and a net change in operating assets and liabilities of $205,420 .
-   Net Cash Provided by Investing Activities: $4,540
-   Net Cash Provided by Financing Activities: $80,000, primarily due to the issuance of a convertible note .

#### Liquidity and Capital Resources (as of March 31, 2026)

-   Cash Held in Trust Account: $250,274,966
-   Cash in Operating Account: $10,977
-   Working Capital: $236,274

#### Capital Structure and Debt

-   IPO Proceeds (May 16, 2025): The company raised $241,500,000 from the sale of 24,150,000 Units at $10.00 per Unit .
-   Private Placement Proceeds (May 16, 2025): An additional $3,821,591 was raised from the sale of 3,821,591 Private Placement Warrants at $1.00 per warrant .
-   Initial Trust Account Deposit: Following the IPO and Private Placement, $242,103,750 was deposited into the Trust Account .
-   Transaction Costs: Total transaction costs amounted to $12,213,743, comprising a $1,207,500 cash underwriting fee, an $8,452,500 deferred underwriting fee, and $2,553,743 in other offering costs .
-   Convertible Promissory Notes: The company received $250,000 on July 24, 2025, and $80,000 on January 26, 2026, from investors through non-interest bearing convertible promissory notes . These notes are convertible into units (Class A ordinary shares and redeemable warrants) at $5.00 per unit upon the closing of an Initial Business Combination .
-   Subsequent Events (April 24, 2026): Two additional convertible promissory notes totaling $300,000 were issued with an 8% interest rate, convertible into units at $3.00 per unit upon the closing of an Initial Business Combination .

#### Outlook and Strategy

Renatus Tactical Acquisition Corp I intends to use substantially all funds in its Trust Account to complete its initial business combination . Any remaining proceeds will be allocated as working capital for the target business, future acquisitions, and growth strategies . However, the company’s cash outside the Trust Account is projected to be insufficient for operations over the next twelve months, which raises substantial doubt about its ability to continue as a going concern .

### Related Stocks

- [RTAC.US](https://longbridge.com/en/quote/RTAC.US.md)

## Related News & Research

- [Zenas BioPharma Insider Bought Shares Worth $1,012,800, According to a Recent SEC Filing](https://longbridge.com/en/news/286872009.md)
- [Tomas Kiselak resigns from Zenas BioPharma board after term expiration](https://longbridge.com/en/news/286241504.md)
- [Americas Gold and Silver Reports Record Production and Sales in Q1 2026 as Execution on the Growth Plan Continues at Galena | USAS Stock News](https://longbridge.com/en/news/286470577.md)
- [Here's Why We're Not At All Concerned With Renascience's (TSE:4889) Cash Burn Situation](https://longbridge.com/en/news/286861893.md)
- [Is Wall Street Bullish or Bearish on Fastenal Stock?](https://longbridge.com/en/news/286373793.md)